AzTrials
AzTrials

Coronary Heart DiseasePERIODNCT03443193

Periodization of Exercise Training in Patients With Coronary Heart Disease.

A study testing Exercise training in people with Coronary Heart Disease and Healthy Control, run by Montreal Heart Institute at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The research project includes two components that assess exercise physiology parameters, cerebrovascular reserve, cognitive functions and cardiac function in coronary heart disease patients at rest, during an acute exercise, and after two different periodized training programs. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Coronary Heart Disease, Healthy Control
What is being tested?
Exercise training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
70 participants
Where
1 siteCanada
Study dates
16 Dec 2015to 31 Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Inclusion Criteria for patients with coronary heart disease:

  • Major
  • Adequate physical and mental capacities
  • Autonomy in daily activities
  • Documented coronary artery disease
  • Stable or recent coronary artery disease

Exclusion Criteria for patients with coronary heart disease:

  • Inability to complete the consent form
  • Acute coronary syndrome < 3 months
  • Heart failure
  • Ejection fraction of the left ventricle <40%
  • Coronary artery disease non revascularisable including left main coronary stenosis
  • Waiting for a bridging of the coronary artery
  • Chronic atrial fibrillation
  • Malignant arrhythmias during exercise
  • Restriction to non cardiopulmonary exercise
  • Severe intolerance to exercise

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Cardiovascular prevention and rehabilitation center

    Montreal, Quebec, H1T 1N6

Other trials in Canada

About this study

Official title: The Effects of Periodization Training on Physiological Parameters, Cerebral Oxygenation, Cognitive Functions and Cardiac Remodelling in Coronary Patients.

The research project includes two components that assess exercise physiology parameters, cerebrovascular reserve, cognitive functions and cardiac function in coronary heart disease patients at rest, during an acute exercise, and after two different periodized training programs.

Being tested
Exercise training
Keywords
aerobic exercise training, periodization, cerebral oxygenation and perfusion, cognition
Medical subject headings
Coronary Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Exercise trainingOther

    Patients will undergo three weekly exercise training sessions with periodized high-intensity interval training and resistance training for a period of 12 weeks.

Study groups in NCT03443193
Study groupRoleWhat they receive
Linear trainingExperimentalLinear training consists to a progressive improvement of the training load during the 3 month-program.
Receives: Other: Exercise training
Non-linear trainingExperimentalNon-linear training consists to an undulating progressive improvement of the training load during the 3 month-program.
Receives: Other: Exercise training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Maximal oxygen uptake (VO2peak) with gas exchange

    VO2peak will be measured during maximal exercise test with a gas exchange device. The highest value reached during the exercise phase of the maximal test (ergocycle) will be considered as the VO2peak. We will measure change of VO2peak before and after exercise training.

    Measured: At baseline and following 12 weeks exercise training intervention

Secondary outcomes (4)
  1. Cerebral hemodynamics

    Cerebral hemodynamics will be measured using near-infrared spectroscopy (NIRS) system during maximal and submaximal exercise tests. We will measure change of cerebral hemodynamics before and after exercise training

    Measured: At baseline and following 12 weeks exercise training intervention

  2. Cognitive functions at rest by a by standard pen-paper battery test

    Cognitive functions will be measured at rest with a pen-paper battery test by a neuropsychologist. We will measure change of score to the cognitive tests before and after exercise training.

    Measured: At baseline and following 12 weeks exercise training intervention

  3. Cardiac hemodynamics

    Cardiac hemodynamics will be measured continuously during the maximal exercise test on bike using an impedance cardiography device. We will measure change of cardiac hemodynamics before and after exercise training.

    Measured: At baseline and following 12 weeks exercise training intervention

  4. Standard echocardiographic parameter of left and right ventricular strain

    global longitudinal strain (%) will be measued at rest for both ventricule

    Measured: At baseline and following 12 weeks exercise training intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Feb 2018
  2. Study start16 Dec 2015
  3. Primary completion30 Sep 2017
  4. Study completion31 Dec 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
70 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03443193
Sponsor's protocol ID
MontrealHI 2015-1895
Acronym
PERIOD
Status last verified
Aug 2022
First submitted
22 Jan 2018
Last updated
1 Sep 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Gayda M, Trachsel LD, Besnier F, Boidin M, Lalonge J, Bherer L, Juneau M, Lepretre PM, Nigam A. Effects of different exercise training programs on post-exercise [Formula: see text]O2 recovery responses in patients with coronary heart disease. Eur J Appl Physiol. 2026 Jun;126(6):3393-3406. doi: 10.1007/s00421-026-06146-4. Epub 2026 Feb 25.

    PubMed 41739167
  • Boidin M, David LP, Trachsel LD, Gayda M, Tremblay J, Lalonge J, Juneau M, Nigam A, Henri C. Impact of 2 different aerobic periodization training protocols on left ventricular function in patients with stable coronary artery disease: an exploratory study. Appl Physiol Nutr Metab. 2021 May;46(5):436-442. doi: 10.1139/apnm-2020-0423. Epub 2020 Oct 27.

    PubMed 33108743
  • Trachsel LD, Boidin M, Henri C, Fortier A, Lalonge J, Juneau M, Nigam A, Gayda M. Women and men with coronary heart disease respond similarly to different aerobic exercise training modalities: a pooled analysis of prospective randomized trials. Appl Physiol Nutr Metab. 2021 May;46(5):417-425. doi: 10.1139/apnm-2020-0650. Epub 2020 Oct 23.

    PubMed 33096006

Questions about this trial

What is this clinical trial studying?

A study testing Exercise training in people with Coronary Heart Disease and Healthy Control, run by Montreal Heart Institute at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Sep 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Maximal oxygen uptake (VO2peak) with gas exchange (time frame: At baseline and following 12 weeks exercise training intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03443193, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Sep 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in